Business · 05/01/1999Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Medical Imaging Drugs and Biologics Guidance
Summary
The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on developing medical imaging drugs and biologics until February 12, 1999, in response to a request for an extension.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →